[go: up one dir, main page]

CN108030808A - A kind of pulvis using lotus leaf as the prevention Diseases of Cow syndrome of main component - Google Patents

A kind of pulvis using lotus leaf as the prevention Diseases of Cow syndrome of main component Download PDF

Info

Publication number
CN108030808A
CN108030808A CN201711454968.1A CN201711454968A CN108030808A CN 108030808 A CN108030808 A CN 108030808A CN 201711454968 A CN201711454968 A CN 201711454968A CN 108030808 A CN108030808 A CN 108030808A
Authority
CN
China
Prior art keywords
vitamin
postpartum
lotus leaf
parts
cows
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711454968.1A
Other languages
Chinese (zh)
Inventor
李心慰
刘国文
房志愿
李小兵
杜希良
史珍
王哲
马赫然
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jilin University
Original Assignee
Jilin University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jilin University filed Critical Jilin University
Priority to CN201711454968.1A priority Critical patent/CN108030808A/en
Publication of CN108030808A publication Critical patent/CN108030808A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/191Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135Compounds containing heavy metals
    • A61K31/714Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/18Iodine; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/748Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/62Nymphaeaceae (Water-lily family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明主要是以荷叶和一些抗氧化作用物质来防治围产期奶牛因酮病而引起的一系列综合征。主要作用是能够防治奶牛产后因饲养管理不当和奶牛自身生理因素易患的一些产后疾病。主要组是分葡萄糖酸钙、葡萄糖酸钾、加碘食盐、丙二醇、维生素A、维生素D、维生素E、维生素B12、烟酸,类胡萝卜素、荷叶碱。主要预防奶牛产后瘫痪、产后出血、胎衣不下、奶牛酮病、皱胃变位、产乳下降、脂肪肝、以及子宫内膜炎。本发明组分严禁安全性高,制作简单、材料易得、制作成本低廉,能够及时补充奶牛产后所需的营养和微量元素能对于预防奶牛产后综合征具有良好的效果。能够大大的降低养殖成本具有较高的经济效益。The invention mainly uses lotus leaf and some antioxidant substances to prevent and treat a series of syndromes caused by ketosis in dairy cows in the perinatal period. The main function is to prevent some postpartum diseases that are susceptible to postpartum cows due to improper feeding management and physiological factors of the cows themselves. The main groups are calcium gluconate, potassium gluconate, iodized salt, propylene glycol, vitamin A, vitamin D, vitamin E, vitamin B 12 , niacin, carotenoids, and nuciferine. It mainly prevents postpartum paralysis, postpartum hemorrhage, retained placenta, cow ketosis, dislocation of abomasum, decreased milk production, fatty liver, and endometritis. The components of the invention are strictly safe, simple to manufacture, easy to obtain, and low in production cost, and can timely supplement the nutrition and trace elements required by postpartum cows, and have a good effect on preventing postpartum syndrome of dairy cows. It can greatly reduce the cost of breeding and has high economic benefits.

Description

一种以荷叶为主要成分的防治围产期奶牛综合征的粉剂A powder for preventing and treating peripartum dairy cow syndrome with lotus leaf as the main component

技术领域technical field

本发明属于畜牧技术领域。The invention belongs to the technical field of animal husbandry.

背景技术Background technique

对于奶牛来说围产期是一个非常重要的阶段,处于围产期的奶牛由于妊娠的作用奶牛干物质摄入下降,机体又必须需要大量能量供机体消耗并且还要合成各种蛋白质和胎儿所必须的一些物质,这种能量需求大于供给成为能量负平衡。能量负平衡下机体只能利用体内脂肪分解来提供机体需要的能量,合成所需要的各种物质,最终脂肪动员加剧使得游离脂肪酸增多,脂肪酸的去路主要有三个:1)完全氧化生成CO2, 和水为机体提供能量。2)不完全氧化生成酮体,血液中大量游离脂肪酸到肝组织氧化分解成乙酰辅酶A供能,由于摄食减少机体中能够和乙酰辅酶A结合的草酰乙酸减少,最终过多的乙酰辅酶A合成酮体即乙酰乙酸、β-羟丁酸、丙酮。3)再次酯化形成甘油三脂。由于干物质摄入较少奶牛体内葡萄糖浓度较低,肝脏产生的大量酮体在满足机体需要后而大大剩余而形成酮病。The perinatal period is a very important stage for dairy cows. Due to the effect of pregnancy, the dry matter intake of dairy cows in the perinatal period decreases, and the body needs a lot of energy for the body to consume and to synthesize various proteins and the fetus. Some substances are necessary, and this energy demand is greater than the supply to become a negative energy balance. Under the negative energy balance, the body can only use fat decomposition in the body to provide the energy needed by the body and synthesize various substances needed. Finally, fat mobilization intensifies and free fatty acids increase. There are three main outlets for fatty acids: 1) complete oxidation to generate CO 2 , and water provide energy for the body. 2) Incomplete oxidation to generate ketone bodies, a large amount of free fatty acids in the blood are oxidized and decomposed into acetyl-CoA for energy supply in the liver tissue. Due to the reduction in food intake, the oxaloacetate that can combine with acetyl-CoA in the body decreases, and eventually too much acetyl-CoA Synthetic ketone bodies are acetoacetate, β-hydroxybutyrate, and acetone. 3) Esterification again to form triglycerides. Due to the low glucose concentration in dairy cows with less dry matter intake, a large amount of ketone bodies produced by the liver are left behind after meeting the body's needs, resulting in ketosis.

围产期奶牛经历妊娠-分娩-泌乳的一系列生理学变动,加之日粮转换等导致干物质摄入减少,同时泌乳启动、能量需求增加而处于能量负平衡状态。上述诸多因素的单独或者叠加作用可导致奶牛内分泌及免疫机能紊乱,使得奶牛罹患生产性疾病(如脂肪肝、酮病和低钙血症等)的风险大大增加。当酮病发生时,体内酮体内不仅有大量酮体积累同时在生成酮体时产生大量活性氧,大量活性氧会造成机体很多损伤,并引起很多疾病。这些疾病往往能引起奶产量和生产性能下降,并由此造成淘汰率和兽医治疗成本增加,从而给奶牛造成了巨大的影响。During the peripartum period, dairy cows undergo a series of physiological changes from pregnancy to parturition to lactation, coupled with diet switching, etc., which lead to a decrease in dry matter intake, and at the same time lactation starts, energy demand increases, and they are in a state of negative energy balance. The single or combined effects of the above factors can lead to endocrine and immune dysfunction in dairy cows, which greatly increases the risk of dairy cows suffering from production diseases (such as fatty liver, ketosis and hypocalcemia, etc.). When ketosis occurs, the ketone body not only accumulates a large amount of ketone bodies, but also produces a large amount of active oxygen when forming ketone bodies. A large amount of active oxygen will cause a lot of damage to the body and cause many diseases. These diseases often have a disproportionate impact on dairy cows by causing reduced milk production and performance, resulting in increased culling rates and veterinary treatment costs.

围产期奶牛干物质摄入不足使奶牛所需的矿物质(如:钙、镁、钾等)不足以满足机体需要,加之奶牛持续泌乳更需要大量的矿物质来满足机体需要。若日粮中没有及时的补充这些矿物质则奶牛易患低血钙、低血镁症等矿物质缺乏症,继而在奶牛产犊时因钙离子缺乏而发生子宫收缩无力进而造成胎衣不下,产后瘫痪。Insufficient dry matter intake of dairy cows during the peripartum period makes the minerals (such as calcium, magnesium, potassium, etc.) required by dairy cows insufficient to meet the needs of the body, and the continuous lactation of dairy cows requires a large amount of minerals to meet the needs of the body. If these minerals are not supplemented in time in the diet, the dairy cows are prone to mineral deficiencies such as hypocalcemia and hypomagnesemia, and then the uterine contraction is weak due to the lack of calcium ions when the cows are calving, resulting in retained placenta. paralysis.

当代我国奶牛饲养属于集约化大型养殖产业,但由于起步较晚很多饲养水平较低。由于围产期奶牛经历妊娠-分娩-泌乳的一系列生理学变动,加之日粮转换等导致干物质摄入减少,同时泌乳启动、能量需求增加而处于能量负平衡状态。上述诸多因素的单独或者叠加作用可导致奶牛内分泌及免疫机能紊乱,使得奶牛免疫抵抗力下降加之产后护理不当使奶牛容易发生子宫内膜炎,以及其他产道炎症,从而使得奶牛下次受胎率降低对奶牛业造成巨大经济损失。Dairy cattle breeding in contemporary my country is an intensive large-scale breeding industry, but due to its late start, many breeding levels are low. During the transition period, dairy cows experience a series of physiological changes from pregnancy to parturition to lactation, coupled with dietary changes, which lead to a decrease in dry matter intake, and at the same time lactation starts, energy demand increases, and they are in a state of negative energy balance. The single or superimposed effects of the above factors can lead to endocrine and immune dysfunction of dairy cows, resulting in decreased immune resistance of dairy cows. In addition, improper postpartum care makes dairy cows prone to endometritis and other inflammations of the birth canal, thereby reducing the next conception rate of dairy cows. The dairy industry causes huge economic losses.

发明内容Contents of the invention

本发明的目的是以荷叶和富含β-胡萝卜素的螺旋藻和一些微量元素的特殊配方以防治围产期奶牛因患酮病而引起一系列综合征的以荷叶为主要成分的防治围产期奶牛综合征的粉剂。The purpose of the present invention is to prevent and treat a series of syndromes caused by ketosis in dairy cows during the peripartum period by using lotus leaves, spirulina rich in β-carotene and a special formula of some trace elements with lotus leaves as the main component. Powder for Peripartum Cow Syndrome.

本发明组成有效成份的重量份数是:The parts by weight that the present invention forms active ingredient is:

葡萄糖酸钙 25-38 维生素A 5-7 荷叶 266—400Calcium gluconate 25-38 Vitamin A 5-7 Lotus leaf 266—400

葡萄糖酸钾 20-32 维生素D 2-4 螺旋藻 10-16Potassium Gluconate 20-32 Vitamin D 2-4 Spirulina 10-16

丙酸镁 12-20 维生素E 4-6 保奶粉 5-10Magnesium propionate 12-20 Vitamin E 4-6 Milk powder 5-10

加碘食盐 9-10 苏打粉 18-20。Iodized salt 9-10 Baking soda 18-20.

本发明组成有效成份的重量份数是:The parts by weight that the present invention forms active ingredient is:

葡萄糖酸钙 38 维生素A 7 荷叶266Calcium gluconate 38 Vitamin A 7 Lotus leaf 266

葡萄糖酸钾 32 维生素D 2 螺旋藻10Potassium Gluconate 32 Vitamin D 2 Spirulina 10

丙酸镁 20 维生素E 6 保奶粉10Magnesium propionate 20 Vitamin E 6 Milk powder 10

加碘食盐 9Iodized table salt 9

苏打粉 19。baking soda 19.

本发明组成有效成份的重量份数是:The parts by weight that the present invention forms active ingredient is:

葡萄糖酸钙 36 维生素A 7 荷叶300Calcium Gluconate 36 Vitamin A 7 Lotus Leaf 300

葡萄糖酸钾 30 维生素D 2 螺旋藻11Potassium Gluconate 30 Vitamin D 2 Spirulina 11

丙酸镁 20 维生素E 6 保奶粉8Magnesium propionate 20 Vitamin E 6 Milk powder 8

加碘食盐 10Iodized table salt 10

苏打粉 19。baking soda 19.

本发明组成有效成份的重量份数是:The parts by weight that the present invention forms active ingredient is:

葡萄糖酸钙 30 维生素A 6 荷叶350Calcium Gluconate 30 Vitamin A 6 Lotus Leaf 350

葡萄糖酸钾 25 维生素D 3 螺旋藻13Potassium Gluconate 25 Vitamin D 3 Spirulina 13

丙酸镁 20 维生素E 5 保奶粉7Magnesium propionate 20 Vitamin E 5 Milk powder 7

加碘食盐 9.5Iodized table salt 9.5

苏打粉 20。Baking soda 20.

本发明组成有效成份的重量份数是:The parts by weight that the present invention forms active ingredient is:

葡萄糖酸钙 25 维生素A 5 荷叶400Calcium Gluconate 25 Vitamin A 5 Lotus Leaf 400

葡萄糖酸钾 20 维生素D 4 螺旋藻16Potassium Gluconate 20 Vitamin D 4 Spirulina 16

丙酸镁 18 维生素E 4 保奶粉份 5Magnesium Propionate 18 Vitamin E 4 Milk Powder Servings 5

加碘食盐 10Iodized table salt 10

苏打粉 18。baking soda 18.

本发明能够有效的解决技术背景所存在的问题,使奶牛能够安全渡过围产期,且本发明原材料极易得到价格异常低廉,在保障奶牛健康的同时,能够大大养殖成本,提高养殖企业收益。本发明将荷叶和螺旋藻作为主要成分来防治围产期奶牛因酮病而引起的炎症,产奶量下降,产后瘫痪等一系列产后综合症疾病在国内属于首例。通过对以上奶牛易得病研究分析本产品综合发病原因,发病机制等多个方面的研究本发明加入为围产期提供营养物质补充各种所缺养料。同时加入荷叶碱和富含β-胡萝卜素的螺旋藻和一些微量元素的特殊配方以防治奶牛临床酮病、产奶量下降、产后瘫痪、胎衣不下和产后奶牛产道炎症以及在一定程度上提高受胎率。The present invention can effectively solve the problems existing in the technical background, so that dairy cows can safely pass through the perinatal period, and the raw materials of the present invention are extremely easy to obtain and the price is extremely low. While ensuring the health of dairy cows, it can greatly reduce the cost of breeding and increase the income of breeding enterprises . The invention uses lotus leaf and spirulina as the main components to prevent and treat a series of postpartum syndrome diseases such as ketosis, decreased milk production, and postpartum paralysis in dairy cows during the peripartum period, which is the first case in China. Through research on the above-mentioned milk cows prone to diseases and analysis of the comprehensive pathogenesis of this product, the research of multiple aspects such as pathogenesis, the present invention adds nutrients for the perinatal period to supplement various nutrients that are lacking. At the same time, add nuciferine, spirulina rich in β-carotene and a special formula of some trace elements to prevent and treat clinical ketosis, decreased milk production, postpartum paralysis, retained placenta and postpartum dairy cow birth canal inflammation and to a certain extent improve conception rate.

具体实施方式Detailed ways

本发明组成有效成份的重量份数是:The parts by weight that the present invention forms active ingredient is:

葡萄糖酸钙 25-38 维生素A 5-7 荷叶 266—400Calcium gluconate 25-38 Vitamin A 5-7 Lotus leaf 266—400

葡萄糖酸钾 20-32 维生素D 2-4 螺旋藻 10-16Potassium Gluconate 20-32 Vitamin D 2-4 Spirulina 10-16

丙酸镁 12-20 维生素E 4-6 保奶粉 5-10Magnesium propionate 12-20 Vitamin E 4-6 Milk powder 5-10

加碘食盐 9-10 苏打粉 18-20;Iodized salt 9-10 Baking soda 18-20;

采用常规粉剂制备方法制备。It is prepared by conventional powder preparation method.

本发明组成有效成份的重量份数是:The parts by weight that the present invention forms active ingredient is:

葡萄糖酸钙 38 维生素A 7 荷叶266Calcium gluconate 38 Vitamin A 7 Lotus leaf 266

葡萄糖酸钾 32 维生素D 2 螺旋藻10Potassium Gluconate 32 Vitamin D 2 Spirulina 10

丙酸镁 20 维生素E 6 保奶粉10Magnesium propionate 20 Vitamin E 6 Milk powder 10

加碘食盐 9Iodized table salt 9

苏打粉 19;baking soda 19;

采用常规粉剂制备方法制备。It is prepared by conventional powder preparation method.

本发明组成有效成份的重量份数是:The parts by weight that the present invention forms active ingredient is:

葡萄糖酸钙 36 维生素A 7 荷叶300Calcium Gluconate 36 Vitamin A 7 Lotus Leaf 300

葡萄糖酸钾 30 维生素D 2 螺旋藻11Potassium Gluconate 30 Vitamin D 2 Spirulina 11

丙酸镁 20 维生素E 6 保奶粉8Magnesium propionate 20 Vitamin E 6 Milk powder 8

加碘食盐 10Iodized table salt 10

苏打粉 19;baking soda 19;

采用常规粉剂制备方法制备。It is prepared by conventional powder preparation method.

本发明组成有效成份的重量份数是:The parts by weight that the present invention forms active ingredient is:

葡萄糖酸钙 30 维生素A 6 荷叶350Calcium Gluconate 30 Vitamin A 6 Lotus Leaf 350

葡萄糖酸钾 25 维生素D 3 螺旋藻13Potassium Gluconate 25 Vitamin D 3 Spirulina 13

丙酸镁 20 维生素E 5 保奶粉7Magnesium propionate 20 Vitamin E 5 Milk powder 7

加碘食盐 9.5Iodized table salt 9.5

苏打粉 20;Baking soda 20;

采用常规粉剂制备方法制备。It is prepared by conventional powder preparation method.

本发明组成有效成份的重量份数是:The parts by weight that the present invention forms active ingredient is:

葡萄糖酸钙 25 维生素A 5 荷叶400Calcium Gluconate 25 Vitamin A 5 Lotus Leaf 400

葡萄糖酸钾 20 维生素D 4 螺旋藻16Potassium Gluconate 20 Vitamin D 4 Spirulina 16

丙酸镁 18 维生素E 4 保奶粉份 5Magnesium Propionate 18 Vitamin E 4 Milk Powder Servings 5

加碘食盐 10Iodized table salt 10

苏打粉 18;baking soda 18;

采用常规粉剂制备方法制备。It is prepared by conventional powder preparation method.

本发明治疗组组份:(以下均采用常规的粉剂制备方法制备)Components of the treatment group of the present invention: (the following are all prepared by conventional powder preparation methods)

治疗组A:Treatment group A:

葡萄糖酸钙 38份 维生素A 7份 荷叶266份38 parts of calcium gluconate, 7 parts of vitamin A, 266 parts of lotus leaf

葡萄糖酸钾 32 份 维生素D 2份 螺旋藻10份Potassium gluconate 32 parts Vitamin D 2 parts Spirulina 10 parts

丙酸镁 20份 维生素E 6份 保奶粉10份Magnesium propionate 20 parts Vitamin E 6 parts Milk powder 10 parts

加碘食盐 9份9 parts iodized table salt

苏打粉 19份19 parts baking soda

治疗组B:Treatment group B:

葡萄糖酸钙 36份 维生素A 7份 荷叶300份36 parts of calcium gluconate, 7 parts of vitamin A, 300 parts of lotus leaf

葡萄糖酸钾 30 份 维生素D 2份 螺旋藻11份Potassium gluconate 30 parts Vitamin D 2 parts Spirulina 11 parts

丙酸镁 20份 维生素E 6份 保奶粉8份20 parts of magnesium propionate, 6 parts of vitamin E, 8 parts of milk powder

加碘食盐 10份10 parts iodized salt

苏打粉 19份19 parts baking soda

治疗组C:Treatment group C:

葡萄糖酸钙 30份 维生素A 6份 荷叶350份30 parts of calcium gluconate, 6 parts of vitamin A, 350 parts of lotus leaf

葡萄糖酸钾 25份 维生素D 3份 螺旋藻13份Potassium gluconate 25 parts Vitamin D 3 parts Spirulina 13 parts

丙酸镁 20份 维生素E 5份 保奶粉7份20 parts of magnesium propionate, 5 parts of vitamin E, 7 parts of milk powder

加碘食盐 9.5份9.5 parts iodized table salt

苏打粉 20份20 parts baking soda

治疗组D:Treatment group D:

葡萄糖酸钙 25份 维生素A 5份 荷叶400份25 parts of calcium gluconate, 5 parts of vitamin A, 400 parts of lotus leaf

葡萄糖酸钾 20份 维生素D 4份 螺旋藻16份Potassium gluconate 20 parts Vitamin D 4 parts Spirulina 16 parts

丙酸镁 18份 维生素E 4份 保奶粉份 5Magnesium propionate 18 parts Vitamin E 4 parts Milk powder 5 parts

加碘食盐 10份10 parts iodized salt

苏打粉 18份Baking soda 18 parts

本发明能够有效的解决技术背景所存在的问题,使奶牛能够安全渡过围产期,且本发明原材料极易得到价格异常低廉,在保障奶牛健康的同时,能够大大养殖成本,提高养殖企业收益。The present invention can effectively solve the problems existing in the technical background, so that dairy cows can safely pass through the perinatal period, and the raw materials of the present invention are extremely easy to obtain and the price is extremely low. While ensuring the health of dairy cows, it can greatly reduce the cost of breeding and increase the income of breeding enterprises .

本发明的主要特点是加入荷叶和富含β-胡萝卜素的螺旋藻和一些微量元素的特殊配方以防治围产期奶牛因患酮病而引的一系列综合征。荷叶为睡莲科植物莲,中医认为其性味苦涩,平,归肝,肺,胃,心经有清署利湿,生发清阳,凉血止血等功效。除此之外大量研究证明荷叶中富含的荷叶碱和黄酮类物质具有抑菌杀菌作用,同时也具有抗氧化作用。The main feature of the invention is that lotus leaves, spirulina rich in beta-carotene and some trace elements are added to the special formula to prevent and treat a series of syndromes caused by ketosis in dairy cows during the transition period. Lotus leaf is a plant of Nymphaeaceae. Traditional Chinese medicine believes that its nature and flavor are bitter and astringent, calm, and it returns to the liver, lungs, stomach, and heart meridian. In addition, a large number of studies have proved that the rich nuciferine and flavonoids in lotus leaves have antibacterial and bactericidal effects, and also have antioxidant effects.

本发明产品主要突出的是添加荷叶和螺旋藻,荷叶中含有的大量荷叶碱对机体炎症反应具有抑制作用,主要是通过荷叶碱分子与炎症激活物结合使其失去与炎性细胞结合的能力从而炎性细胞不能释放大量炎性因子而起到抗炎作用。与此同时荷叶中也富含的黄酮类物质,是大多数氧自由基的清除剂,可以提高超氧化物歧化酶的活力,减少丙二醛及氧化低密度脂蛋白的生成,大量实验证明荷叶碱具有抑菌作用,荷叶碱通过破坏细菌的细胞壁和细胞膜抑制细菌的有丝分裂亦或影响细胞能量代谢等多种途径从而达到抑菌杀菌效果。从而减少了奶牛产后因细菌感染发生炎症。从中医来讲奶牛产后气虚,血虚而荷叶主治产后气虚血淤,具有止血、理脾健胃的功效。能够很快起到奶牛产后止血防止奶牛出血继发感染。而螺旋藻富含的β-胡萝卜素具有抗氧化作用,围产期奶牛发生酮病时体内产生大量活性氧,对机造成损伤,特别是肝脏损伤较为严重,更加剧了体内氧化与抗氧化失衡,而围产期补充抗氧化物质能够有效缓解体内因活性氧过多对机体造成的损伤。The main highlight of the product of the present invention is the addition of lotus leaf and spirulina. A large amount of nuciferine contained in lotus leaf has an inhibitory effect on the body’s inflammatory response, mainly through the combination of nuciferine molecules and inflammatory activators to make it lose its interaction with inflammatory cells. Therefore, inflammatory cells cannot release a large number of inflammatory factors and play an anti-inflammatory role. At the same time, lotus leaves are also rich in flavonoids, which are scavengers of most oxygen free radicals, can increase the activity of superoxide dismutase, reduce the generation of malondialdehyde and oxidized low-density lipoprotein, a large number of experiments have proved Nuciferine has antibacterial effect. Nuciferine can inhibit bacterial mitosis or affect cell energy metabolism by destroying bacterial cell walls and cell membranes to achieve antibacterial and bactericidal effects. Thereby reducing the postpartum inflammation of dairy cows due to bacterial infection. From the perspective of traditional Chinese medicine, dairy cows have postpartum qi deficiency and blood deficiency, while lotus leaves are mainly used to treat postpartum qi deficiency and blood stasis, and have the effects of stopping bleeding, regulating the spleen and strengthening the stomach. It can quickly stop the postpartum bleeding of dairy cows and prevent secondary infection of dairy cows. The β-carotene rich in spirulina has anti-oxidation effect, and a large amount of reactive oxygen species will be produced in the body when cows undergo ketosis during the peripartum period, causing damage to the machine, especially the liver damage is more serious, which exacerbates the imbalance between oxidation and anti-oxidation in the body , and perinatal supplementation of antioxidant substances can effectively alleviate the damage caused by excessive active oxygen in the body.

本发明粉剂使用方法:奶牛产前21天-产后21天,每周饲喂一次,在每周一进食前取本产品一袋加入到5-10㎏37℃水中,然后灌服到瘤胃中,其他饲喂流程正常。连续灌服6次每周一次。The method of using the powder of the present invention: cows are fed once a week from 21 days before delivery to 21 days after delivery, take a bag of this product and add it to 5-10kg 37°C water before eating every Monday, and then pour it into the rumen, and other The feeding process is normal. Continuously fed 6 times once a week.

本发明主要预防和治疗原理及有益效果是:本产品使用容易采购且低廉的葡萄糖酸钙、葡萄糖酸钾不仅及时的补充围产期奶牛体内所需的葡萄糖,而且也能够提供奶牛因干物质量摄入不足而缺少的钙、钾离子防止奶牛患低血钙和低血钾症。丙酸镁也为奶牛瘤胃提供丙酸使奶牛利用丙酸进行糖异生合成其他机体所需物质,镁离子有效预防奶牛低血镁症且丙酸镁极易吸收。各种维生素能够有效补充围产期奶牛因干物质摄入不足而缺乏的营养物质。本产品的亮点之处在于加入荷叶和保奶粉螺旋藻。荷叶所含的荷叶碱能够有效抑制细菌(不包含瘤胃内有益菌),同时荷叶在中医上也有效治疗奶牛产后气虚、血淤、血虚同时具有理脾健胃的功效在碱性条件下荷叶碱发挥的作用更好,因此加入苏打粉。而螺旋藻含有大量β-胡萝卜素具有抗炎和抗氧化的功效。而保奶粉主要组成是:维生素E:硒=1236IU:54㎎,维生素B12 5㎎,烟酸4㎎,能够有效提高围产期奶牛产奶量和提高受胎率。本发明产品主要突出的是添加荷叶和螺旋藻,荷叶中含有的大量荷叶碱对机体炎症反应具有抑制作用,主要是通过荷叶碱分子与炎症激活物结合使其失去与炎性细胞结合的能力从而炎性细胞不能释放大量炎性因子而起到抗炎作用。与此同时荷叶中也富含的黄酮类物质,是大多数氧自由基的清除剂,可以提高超氧化物歧化酶的活力,减少丙二醛及氧化低密度脂蛋白的生成,大量实验证明荷叶碱具有抑菌作用,荷叶碱通过破坏细菌的细胞壁和细胞膜抑制细菌的有丝分裂亦或影响细胞能量代谢等多种途径从而达到抑菌杀菌效果。从而减少了奶牛产后因细菌感染发生炎症。从中医来讲奶牛产后气虚,血虚而荷叶主治产后气虚血淤,具有止血、理脾健胃的功效。能够很快起到奶牛产后止血防止奶牛出血继发感染。而螺旋藻富含的β-胡萝卜素具有抗氧化作用,围产期奶牛发生酮病时体内产生大量活性氧,对机造成损伤,特别是肝脏损伤较为严重,更加剧了体内氧化与抗氧化失衡,而围产期补充抗氧化物质能够有效缓解体内因活性氧过多对机体造成的损伤。本产品经过大量实验优化组合科学合理、安全性高、且效果显著。The main preventive and therapeutic principles and beneficial effects of the present invention are: this product uses calcium gluconate and potassium gluconate, which are easy to purchase and cheap, not only timely supplement the glucose needed in the perinatal dairy cows, but also can provide the dry matter intake of dairy cows. Insufficient calcium and potassium ions prevent dairy cows from suffering from hypocalcemia and hypokalemia. Magnesium propionate also provides propionic acid for the rumen of dairy cows so that the cows can use propionic acid for gluconeogenesis to synthesize other substances needed by the body. Magnesium ions can effectively prevent hypomagnesemia in dairy cows and magnesium propionate is easily absorbed. Various vitamins can effectively supplement the nutritional substances that dairy cows lack during the transition period due to insufficient dry matter intake. The highlight of this product is the addition of lotus leaf and milk powder spirulina. Nuciferine contained in lotus leaves can effectively inhibit bacteria (excluding beneficial bacteria in the rumen), and lotus leaves are also effective in treating postpartum qi deficiency, blood stasis, and blood deficiency in dairy cows in traditional Chinese medicine. It also has the effect of regulating the spleen and strengthening the stomach. Nuciferine plays a better role under certain conditions, so adding soda powder. Spirulina contains a large amount of β-carotene, which has anti-inflammatory and antioxidant effects. The main components of milk protection powder are: vitamin E: selenium = 1236IU: 54㎎, vitamin B 12 5㎎, niacin 4㎎, which can effectively increase the milk production of dairy cows during the peripartum period and increase the conception rate. The main highlight of the product of the present invention is the addition of lotus leaf and spirulina. A large amount of nuciferine contained in lotus leaf has an inhibitory effect on the body’s inflammatory response, mainly through the combination of nuciferine molecules and inflammatory activators to make it lose its interaction with inflammatory cells. Therefore, inflammatory cells cannot release a large number of inflammatory factors and play an anti-inflammatory role. At the same time, lotus leaves are also rich in flavonoids, which are scavengers of most oxygen free radicals, can increase the activity of superoxide dismutase, reduce the generation of malondialdehyde and oxidized low-density lipoprotein, a large number of experiments have proved Nuciferine has antibacterial effect. Nuciferine can inhibit bacterial mitosis or affect cell energy metabolism by destroying bacterial cell walls and cell membranes to achieve antibacterial and bactericidal effects. Thereby reducing the postpartum inflammation of dairy cows due to bacterial infection. From the perspective of traditional Chinese medicine, dairy cows have postpartum qi deficiency and blood deficiency, while lotus leaves are mainly used to treat postpartum qi deficiency and blood stasis, and have the effects of stopping bleeding, regulating the spleen and strengthening the stomach. It can quickly stop the postpartum bleeding of dairy cows and prevent secondary infection of dairy cows. The β-carotene rich in spirulina has anti-oxidation effect, and a large amount of reactive oxygen species will be produced in the body when cows undergo ketosis during the peripartum period, causing damage to the machine, especially the liver damage is more serious, which exacerbates the imbalance between oxidation and anti-oxidation in the body , and perinatal supplementation of antioxidant substances can effectively alleviate the damage caused by excessive active oxygen in the body. This product has undergone a large number of experiments to optimize the combination to be scientific and reasonable, with high safety and remarkable effect.

本产品原材料易得,价格低廉于奶牛口感较好,使用简单、安全、有效。从营养角度和发病机制上研究能够有效预防和治疗围产期奶牛酮病,产奶量下降,产后瘫痪和产后子宫内膜炎,以及能在一定程度上提高受胎率,并在实验中上述作用皆得到了验证。在奶牛养殖中大大减少了兽医工作,更为养殖企业增加收益。The raw materials of this product are easy to obtain, the price is lower than that of cows, and the taste is better. It is simple, safe and effective to use. Research from the perspective of nutrition and pathogenesis can effectively prevent and treat peripartum cow ketosis, decreased milk production, postpartum paralysis and postpartum endometritis, and can increase the conception rate to a certain extent, and the above effects in the experiment have all been verified. In dairy farming, the work of veterinarians is greatly reduced, and the income of farming enterprises is increased.

由于本产品为进食前灌服,因此在灌服时容易将胃导管插入到器官或肺内,所以在灌服需要有一定的兽医知识人员操作或者有专业兽医人员在场监督亦或者具有一定操作经验的老技术人员。Because this product is fed before eating, it is easy to insert the gastric catheter into the organ or lung during feeding, so it needs to be operated by personnel with certain veterinary knowledge or supervised by professional veterinary personnel or have certain operating experience. old technician.

为了进一步证实本产品的效果实施了以下九组实验,具体操作和说明如下:In order to further confirm the effect of this product, the following nine groups of experiments were carried out. The specific operations and instructions are as follows:

本实验采用对照组、预防组与治疗组分步的方案进行操作。This experiment adopts the step-by-step scheme of control group, prevention group and treatment group.

实验动物的选择和分组:选取某集约化万头奶牛场,胎次、年龄、体况以及预产期极为接近健康奶牛320头。分为四个对照组,每组40头,实验组160头,标记为预防组1,40头、预防组2,40头、预防组3,40头、预防组4,40头。Selection and grouping of experimental animals: Select an intensive dairy farm with 10,000 cows, 320 cows with parity, age, body condition and expected date of delivery are very close to healthy cows. Divided into four control groups, 40 animals in each group, 160 animals in the experimental group, marked as prevention group 1, 40 animals, prevention group 2, 40 animals, prevention group 3, 40 animals, prevention group 4, 40 animals.

实验组和对照组均按照NRC标准饲喂,从预产期前21天到产后21天,每周饲喂一次,在每周一进食前取本产品一袋加入到5-10㎏37℃水中,然后灌服到瘤胃中,其他饲喂流程正常。连续灌服6次每周一次。Both the experimental group and the control group were fed according to NRC standards. From 21 days before the expected date of delivery to 21 days after delivery, they were fed once a week. Before eating every Monday, take a bag of this product and add it to 5-10kg of water at 37°C, and then feed Serve in the rumen, other feeding processes are normal. Continuously fed 6 times once a week.

实验操作:实验组1、2、3、4分别对应预防组1、2、3、4的本产品量使用。Experimental operation: Experimental groups 1, 2, 3, and 4 correspond to the amount of this product in prevention groups 1, 2, 3, and 4, respectively.

在42天内对照组和预防组按照NRC标准同等饲喂,每天采血检测酮病、产道炎症、及记录每周奶牛的平均产奶量和观察奶牛是否瘫痪,认真做好每一步,42天后统计结果。Within 42 days, the control group and the prevention group were fed equally according to the NRC standard. Blood was collected every day to detect ketosis and inflammation of the birth canal, and the average milk production of cows per week was recorded and whether the cows were paralyzed. Every step was done carefully, and the results were counted after 42 days. .

连续检测42天结果:Results of 42 consecutive days of testing:

预防组1的实施结果:Implementation results of prevention group 1:

两组酮病、产后瘫痪、产道炎症的病例数The number of cases of ketosis, postpartum paralysis, and inflammation of the birth canal in the two groups

.

产奶量的统计结果(单位:L/平均每头):Statistical results of milk production (unit: L/average per head):

.

预防组2的实施结果:Implementation results of prevention group 2:

两组酮病、产后瘫痪、产道炎症的病例数The number of cases of ketosis, postpartum paralysis, and inflammation of the birth canal in the two groups

.

产奶量的统计结果(单位:L/平均每头):Statistical results of milk production (unit: L/average per head):

.

预防组3的实施结果:Implementation results of prevention group 3:

两组酮病、产后瘫痪、产道炎症的病例数:Number of cases of ketosis, postpartum paralysis, and inflammation of the birth canal in the two groups:

.

产奶量的统计结果(单位:L/平均每头):Statistical results of milk production (unit: L/average per head):

.

预防组4的实施结果:Implementation results of prevention group 4:

两组酮病、产后瘫痪、产道炎症的病例数:Number of cases of ketosis, postpartum paralysis, and inflammation of the birth canal in the two groups:

.

产奶量的统计结果(单位:L/平均每头):Statistical results of milk production (unit: L/average per head):

.

通过临床病例分析,采用SPASS 19.0软件和t检验进行分析可得出以下结论:Through the analysis of clinical cases, the following conclusions can be drawn by using SPASS 19.0 software and t test for analysis:

采用本发明产品能够有效预防奶牛酮病,且与对照组采用本产品很有效预防临床酮病。并且预防组4与对照组差异极显著(P<0.001),酮病的发病率降低了65%。,产后瘫痪下降35%,产后产道炎症降低57.5%,奶牛平均产奶量提高49.61%;因此可以说明本产品对于预防围产期奶牛酮病和提高产奶量具有相当好的效果。Adopting the product of the invention can effectively prevent dairy cow ketosis, and the product is very effective in preventing clinical ketosis compared with the control group. And the difference between the prevention group 4 and the control group was extremely significant (P<0.001), and the incidence of ketosis was reduced by 65%. , postpartum paralysis decreased by 35%, postpartum birth canal inflammation decreased by 57.5%, and the average milk production of dairy cows increased by 49.61%. Therefore, it can be shown that this product has a very good effect on preventing ketosis and increasing milk production in dairy cows during the peripartum period.

上述试验结束后,用本次实验所采用的实验对象同样的分组观察后期五组奶牛的初次受精后的受胎率,预防组和对照组饲喂情况完全一样。其结果如下:After the above experiment was over, the same grouping of the experimental subjects used in this experiment was used to observe the conception rate of the first fertilized dairy cows in the later five groups, and the feeding conditions of the prevention group and the control group were exactly the same. The result is as follows:

受胎情况如下:The conception is as follows:

.

实验结果表明使用本产品和不使用本产品奶牛产后受胎情况明显不同。使用本产品能够大大提高受胎率,其中预防组4的剂量受胎率达到97.5%。因此可证明本发明在围产期饲喂本产品不仅可以预防奶牛酮病还可以提高产后受胎率。The experimental results show that the conception of dairy cows after giving birth is significantly different between using this product and not using this product. The use of this product can greatly increase the conception rate, and the conception rate of the prevention group 4 reached 97.5%. Therefore, it can be proved that feeding the product during the perinatal period of the present invention can not only prevent dairy cow ketosis but also improve the postpartum conception rate.

检验本产品的治疗效果具体实施方案如下:Test the therapeutic effect of this product The specific implementation plan is as follows:

选取某集约化万头奶牛场,胎次、年龄、体况以及其他身体条件相同的产后奶牛200头,经各种生化指标检验(BHBA>1.2mmol/L;GLU<2.5mmol/L;)确诊为酮病。分为四个对照组每组40头,实验组160头,标记为治疗组A,40头、治疗组B,40头、治疗组C,40头、治疗组D,40头。Select 200 postpartum dairy cows with the same parity, age, body condition and other physical conditions in an intensive dairy farm with 10,000 cows, and confirm the diagnosis by various biochemical indicators (BHBA>1.2mmol/L; GLU<2.5mmol/L;) For ketosis. Divided into four control groups with 40 heads in each group and an experimental group with 160 heads, labeled as treatment group A with 40 heads, treatment group B with 40 heads, treatment group C with 40 heads, and treatment group D with 40 heads.

实验分为治疗组和对照组,对照组不加本产品,对照组加本发明产品并按照2中治疗组的量加入本产品。每5天饲喂一次并在饲喂前一天晚上检测奶牛血液中酮病指标BHBA、NEFA、AST、ALT、GLU、连续饲喂30天,检测6次血样。实验结果统计如下:The experiment is divided into a treatment group and a control group. The control group does not add this product, and the control group adds the product of the present invention and adds this product according to the amount of the treatment group in 2. Feed once every 5 days and detect the ketosis indicators BHBA, NEFA, AST, ALT, GLU in the blood of dairy cows the night before feeding, continuously feed for 30 days, and detect 6 blood samples. The statistics of the experimental results are as follows:

BHBA的检测结果(单位:mmol/L):BHBA test results (unit: mmol/L):

.

NEFA检测结果(单位:mmol/L)NEFA test results (unit: mmol/L)

.

GLU的检测结果(单位:mmol/L)GLU test results (unit: mmol/L)

.

AST的检测结果(单位:mmol/L)AST test results (unit: mmol/L)

.

ALT的检测结果(单位:mmol/L)ALT test results (unit: mmol/L)

.

实验结果采用SPASS19.0软件进行t检验分析得出,实验组与对照组差异显著(P<0.05),其中治疗组3、4、两组差异极显著(P<0.01),因此此次试验完全证明了本发明产品能够有效治愈奶牛酮病。The experimental results were analyzed by t test using SPASS19.0 software, and it was found that the experimental group and the control group were significantly different (P<0.05), and the treatment group 3, 4, and the two groups were significantly different (P<0.01), so this experiment is completely It is proved that the product of the invention can effectively cure cow ketosis.

通过实验有力的证明了本发明在预防和治疗围产期奶易发的酮病,产后瘫痪、胎衣不下以及产道炎症效果显著。其中组方4,使最优化的配方组合。并且本产品能提高围产期后奶牛的受胎率,对于奶牛养殖产业具有重要的使用价值。并且本产品绿色环保、安全高效,价格低廉应用于畜牧产业能够给其带来巨大的经济效益。It has been strongly proved by experiments that the present invention has remarkable effects in preventing and treating peripartum milk-prone ketosis, postpartum paralysis, retained placenta and inflammation of the birth canal. Among them, formula 4 is the most optimized formula combination. Moreover, the product can improve the conception rate of dairy cows after the peripartum period, and has important use value for the dairy cattle breeding industry. Moreover, the product is green, environmentally friendly, safe, efficient, and low in price, and its application in the animal husbandry industry can bring huge economic benefits to it.

本发明产品主要突出的是添加荷叶和螺旋藻,荷叶中含有的大量荷叶碱对机体炎症反应具有抑制作用,主要是通过荷叶碱分子与炎症激活物结合使其失去与炎性细胞结合的能力从而炎性细胞不能释放大量炎性因子而起到抗炎作用。与此同时荷叶中也富含的黄酮类物质,是大多数氧自由基的清除剂,可以提高超氧化物歧化酶的活力,减少丙二醛及氧化低密度脂蛋白的生成,大量实验证明荷叶碱具有抑菌作用,荷叶碱通过破坏细菌的细胞壁和细胞膜抑制细菌的有丝分裂亦或影响细胞能量代谢等多种途径从而达到抑菌杀菌效果。从而减少了奶牛产后因细菌感染发生炎症。从中医来讲奶牛产后气虚,血虚而荷叶主治产后气虚血淤,具有止血、理脾健胃的功效。能够很快起到奶牛产后止血防止奶牛出血继发感染。而螺旋藻富含的β-胡萝卜素具有抗氧化作用,围产期奶牛发生酮病时体内产生大量活性氧,对机造成损伤,特别是肝脏损伤较为严重,更加剧了体内氧化与抗氧化失衡,而围产期补充抗氧化物质能够有效缓解体内因活性氧过多对机体造成的损伤。The main highlight of the product of the present invention is the addition of lotus leaf and spirulina. A large amount of nuciferine contained in lotus leaf has an inhibitory effect on the body’s inflammatory response, mainly through the combination of nuciferine molecules and inflammatory activators to make it lose its interaction with inflammatory cells. Therefore, inflammatory cells cannot release a large number of inflammatory factors and play an anti-inflammatory role. At the same time, lotus leaves are also rich in flavonoids, which are scavengers of most oxygen free radicals, can increase the activity of superoxide dismutase, reduce the generation of malondialdehyde and oxidized low-density lipoprotein, a large number of experiments have proved Nuciferine has antibacterial effect. Nuciferine can inhibit bacterial mitosis or affect cell energy metabolism by destroying bacterial cell walls and cell membranes to achieve antibacterial and bactericidal effects. Thereby reducing the postpartum inflammation of dairy cows due to bacterial infection. From the perspective of traditional Chinese medicine, dairy cows have postpartum qi deficiency and blood deficiency, while lotus leaves are mainly used to treat postpartum qi deficiency and blood stasis, and have the effects of stopping bleeding, regulating the spleen and strengthening the stomach. It can quickly stop the postpartum bleeding of dairy cows and prevent secondary infection of dairy cows. The β-carotene rich in spirulina has anti-oxidation effect, and a large amount of reactive oxygen species will be produced in the body when cows undergo ketosis during the peripartum period, causing damage to the machine, especially the liver damage is more serious, which exacerbates the imbalance between oxidation and anti-oxidation in the body , and perinatal supplementation of antioxidant substances can effectively alleviate the damage caused by excessive active oxygen in the body.

Claims (5)

  1. A kind of 1. pulvis using lotus leaf as the prevention Diseases of Cow syndrome of main component, it is characterised in that:Composition effectively into Part parts by weight be:
    Calcium gluconate 25-38 vitamin A 5-7 lotus leaves 266-400
    K-IAO 20-32 vitamin D 2-4 spirulinas 10-16
    Propionic acid magnesium 12-20 vitamin Es 4-6 protects milk powder 5-10
    Iodized salt 9-10 soda ash 18-20.
  2. 2. the pulvis according to claim 1 using lotus leaf as the prevention Diseases of Cow syndrome of main component, its feature It is:Forming the parts by weight of effective ingredient is:
    38 vitamin A of calcium gluconate, 7 lotus leaf 266
    32 vitamin D of K-IAO, 2 spirulina 10
    20 vitamin E 6 of propionic acid magnesium protects milk powder 10
    Iodized salt 9
    Soda ash 19.
  3. 3. the pulvis according to claim 1 using lotus leaf as the prevention Diseases of Cow syndrome of main component, its feature It is:Forming the parts by weight of effective ingredient is:
    36 vitamin A of calcium gluconate, 7 lotus leaf 300
    30 vitamin D of K-IAO, 2 spirulina 11
    20 vitamin E 6 of propionic acid magnesium protects milk powder 8
    Iodized salt 10
    Soda ash 19.
  4. 4. the pulvis according to claim 1 using lotus leaf as the prevention Diseases of Cow syndrome of main component, its feature It is:Forming the parts by weight of effective ingredient is:
    30 vitamin A of calcium gluconate, 6 lotus leaf 350
    25 vitamin D of K-IAO, 3 spirulina 13
    20 vitamin E 5 of propionic acid magnesium protects milk powder 7
    Iodized salt 9.5
    Soda ash 20.
  5. 5. the pulvis according to claim 1 using lotus leaf as the prevention Diseases of Cow syndrome of main component, its feature It is:Forming the parts by weight of effective ingredient is:
    25 vitamin A of calcium gluconate, 5 lotus leaf 400
    20 vitamin D of K-IAO, 4 spirulina 16
    18 vitamin E 4 of propionic acid magnesium protects milk powder part 5
    Iodized salt 10
    Soda ash 18.
CN201711454968.1A 2017-12-28 2017-12-28 A kind of pulvis using lotus leaf as the prevention Diseases of Cow syndrome of main component Pending CN108030808A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711454968.1A CN108030808A (en) 2017-12-28 2017-12-28 A kind of pulvis using lotus leaf as the prevention Diseases of Cow syndrome of main component

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711454968.1A CN108030808A (en) 2017-12-28 2017-12-28 A kind of pulvis using lotus leaf as the prevention Diseases of Cow syndrome of main component

Publications (1)

Publication Number Publication Date
CN108030808A true CN108030808A (en) 2018-05-15

Family

ID=62097691

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711454968.1A Pending CN108030808A (en) 2017-12-28 2017-12-28 A kind of pulvis using lotus leaf as the prevention Diseases of Cow syndrome of main component

Country Status (1)

Country Link
CN (1) CN108030808A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109771467A (en) * 2019-01-17 2019-05-21 吉林大学 A compound eucommia concentrate for improving the resistance of dairy cows during the perinatal period
CN112107629A (en) * 2020-08-31 2020-12-22 吉林大学 Health powder for preventing and treating liver injury of dairy cow with ketosis in perinatal period
RU2739697C1 (en) * 2020-07-27 2020-12-28 Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский ветеринарный институт патологии, фармакологии и терапии" (ФГБНУ "ВНИВИПФиТ") Method for preventing postpartum endometritis in cows
CN112472719A (en) * 2020-11-17 2021-03-12 吉林大学 A powder containing linarin as main ingredient for preventing and treating fatty liver of perinatal milk cow

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106938016A (en) * 2017-03-22 2017-07-11 上林县山水牛畜牧业有限公司 A kind of cow postpartum big tonic liquor and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106938016A (en) * 2017-03-22 2017-07-11 上林县山水牛畜牧业有限公司 A kind of cow postpartum big tonic liquor and preparation method thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109771467A (en) * 2019-01-17 2019-05-21 吉林大学 A compound eucommia concentrate for improving the resistance of dairy cows during the perinatal period
RU2739697C1 (en) * 2020-07-27 2020-12-28 Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский ветеринарный институт патологии, фармакологии и терапии" (ФГБНУ "ВНИВИПФиТ") Method for preventing postpartum endometritis in cows
CN112107629A (en) * 2020-08-31 2020-12-22 吉林大学 Health powder for preventing and treating liver injury of dairy cow with ketosis in perinatal period
CN112107629B (en) * 2020-08-31 2022-03-11 吉林大学 Health powder for preventing and treating liver injury of dairy cow with ketosis in perinatal period
CN112472719A (en) * 2020-11-17 2021-03-12 吉林大学 A powder containing linarin as main ingredient for preventing and treating fatty liver of perinatal milk cow

Similar Documents

Publication Publication Date Title
CN103989026B (en) A kind of anti-oxidant, anti-pollution milk cow composite nutrient licking brick and application thereof
CN103005170B (en) Chinese medicinal herb compound feed additive for preventing and treating postpartum hypogalactia of sow
CN109770078B (en) Feed additive for preventing diarrhea of calves in lactation period and using method thereof
CN108030808A (en) A kind of pulvis using lotus leaf as the prevention Diseases of Cow syndrome of main component
CN106998754A (en) Animal feed supplement and method
CN101983584B (en) An Additive for Increasing Feed Dry Matter Intake of Dairy Cows in Early Lactation
CN103947908A (en) Preparation method of anti-oxidation and anti-pollution multi-nutrient block for dairy cows
CN106343217A (en) Vitamin and mineral nutritive grease for pets and preparation method thereof
CN103355508B (en) Special nutrient block for dairy cows in Qinghai-Xizang region and preparation method thereof
CN112890006B (en) Hematopoietic nutritional feed additive, preparation method and application thereof
CN108077622B (en) Additive for improving production performance of sows, preparation method of additive and mixed feed containing additive
CN106889327A (en) A kind of milk powder for sucking pig and preparation method thereof
CN103734545B (en) High-calcium nutritional lick block for treating antenatal and postnatal paresis of milk cows and preparation method of high-calcium nutritional lick block
CN106721305A (en) It is a kind of to improve compositions of additives of body condition or its production performance and preparation method thereof after Farrowing
CN104171361A (en) Beef cattle daily feed additive
CN105639079A (en) Feed capable of improving immunity of meat-type ducks
CN1985619B (en) Acanthopanax root feed additive and its preparing method
CN103892132B (en) A kind of plant feed addictive promoting piglet growth and preparation method thereof
CN103300226B (en) Feed additive capable of reducing egg weight and increasing laying rate and use method thereof
CN105010829A (en) Health care powder capable of preventing hypocalcemia of high-yield cow at postnatal stage and use method of health care powder
CN113133500B (en) A feed additive for relieving altitude sickness of dairy cows and its using method and feed
CN110037189A (en) Promote Farrowing and mitigates the preparation method of postpartum syndrome feed addictive
CN113475635A (en) Additive premix for relieving oxidative stress of sows
CN106880793B (en) Additive for reducing diarrhea of suckling piglets and application thereof
RU2603266C1 (en) Method of productive qualities and safety increase during nursery period

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180515